How should we communicate implant treatment risk to a patient? by Curtis, Donald A & Sadowsky, Steven J
UCSF
UC San Francisco Previously Published Works
Title
How should we communicate implant treatment risk to a patient?
Permalink
https://escholarship.org/uc/item/8w29k8k0
Journal
Journal of the American Dental Association (1939), 150(6)
ISSN
0002-8177
Authors
Curtis, Donald A
Sadowsky, Steven J
Publication Date
2019-06-01
DOI
10.1016/j.adaj.2019.04.004
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Commentary
Commentary
How should we communicate implant
treatment risk to a patient?
Donald A. Curtis, DMD; Steven J. Sadowsky, DDS
ow do you communicate treatment risk to a patient? When treatment planning with dental
implants, we know there is always some biological uncertainty and the potential forH implant failure. What is the best way to communicate this risk?
Most of us were trained to identify and disclose treatment risk during the patient history or
clinical examination. When we identify a patient who smokes cigarettes, we explain that smoking
increases the risk of experiencing implant failure and suggest that the patient stop smoking. When
we clinically assess a patient who has active periodontal disease, we recommend treatment to
achieve periodontal stability before considering implants. The evidence for some risk factors is
substantial, and we feel grounded in highlighting caution; yet for other risks, the evidence is
inconclusive, and we waver on whether to even mention them. Equally challenging is how to
evaluate and manage comprehensively the care of patients who have multiple apparent risks or
patients who are unaware of their underlying medical risks such as diabetes. The process of riskPatients tend to overestimate the
beneﬁts of medical interventions.
They also tend to underestimate
risks, which is especially true with
elective procedures such as
dental implants.disclosure defaults to a clinician’s intuition and
reasoning rather than a formal or systematic process.
In this commentary, we ask if there is a better way.
We ask 2 questions related to risk disclosure in
implant dentistry. First, why are discussions about
treatment risk and long-term prognosis minimized by
both the patient and clinician? Second, how have
other health care disciplines approached the issue of
risk disclosure?
Patients tend to overestimate the beneﬁts of medi-
cal interventions.1,2 They also tend to underestimate
risks,1 which is especially true with elective procedures
such as dental implants.3 A systematic review of
medical studies in which researchers evaluated patient
expectations of beneﬁts and harms found that in 88%
of the studies, patients overestimated the actual ben-
eﬁts, whereas in 67% of the studies, patients under-Commentaries represent the
opinions of the authors and
not necessarily those of the
American Dental Association.estimated treatment risks.1 The authors concluded that patients have unrealistic positive
expectations of treatment outcomes owing to “optimism bias,” an underlying human characteristic
that is also reinforced by media messages.4,5 It is not surprising that patients tend to overestimate the
functional value of implants,5 underestimate the expertise required for the clinical procedure,5 and
then come to clinicians uninformed about implant complications.6-8 More than 70% of patients
anticipate that implants might last for a lifetime,7 yet more than 30% of patients with implants self-
report complications.9
When patients complete the standard consent form used in most ofﬁces, the risks and beneﬁts of
an intervention are not personalized and remain abstract.10 Consent forms have become longer,
more complicated, and more of a legal formality than a means to inform and educate patients.11
Rather than carefully reading and understanding the disclosure information, patients often defer
to authority12,13 and are unwilling to admit they do not understand what they have been told.
Clinicians also tend to believe that their suggested intervention will be of more beneﬁt than is
actually supported by evidence,14-16 which may be a result of the literature emphasizing positiveJADA 150(6) n http://jada.ada.org n June 2019 481
482outcomes and beneﬁts over harms.17 In addition, the clinician has a vested interest in patient
acceptance of treatment as well as clinical expediency.18 These biases help explain why there is less
engagement by health care providers than patients would like.1,19
If both patients and clinicians are inaccurate in their estimation of risks and beneﬁtsdalbeit for
different reasonsdand if the existing standard consent forms used are incomplete in educating or
disclosing risk to patients, how can the process of risk assessment and disclosure in implant dentistry
be improved?
Decision aids are 1 possible solution, providing a framework to engage the patient and for the
clinician to be more systematic in considering factors inﬂuencing treatment outcomes.1 Decision
aids can take various forms, including questionnaires, pamphlets, videos, or Web-based tools.20 In a
2017 review of decision aids used in surgery, screening, use of medications, and diabetes man-
agement, the authors evaluated 105 studies involving 31,043 patients and concluded that decision
aids improved patients’ knowledge of options, resulted in a more accurate expectation of beneﬁts
and harms, and left fewer patients feeling uninformed.20 Surprisingly, the authors concluded that
decision aids add, on average, only 2.6 minutes to the average consultation visit.20
A decision aid in the form of a risk assessment questionnaire has been proposed as a clinician
checklist21,22 and as an important way to provide feedback to correct patients’ inaccurate percep-
tions of their own risks for a health outcome.23 A risk assessment questionnaire allows risk to be
stratiﬁed within a population so that the unique risk proﬁle of a patient can be identiﬁed and
managed. In medicine, many different risk assessment questionnaires have been developed to es-
timate health outcomes. For example, just in the speciﬁc area of predicting prediabetes, 18 different
risk assessment algorithms have been identiﬁed and compared.24
Disclosing risk associated with the use of dental implants includes legal standards of evaluating
the patient to be competent, adequately informed, and not coerced. Beyond legal requirements, it is
important for the clinician to educate the patient in a systematic way. Unfortunately, our current
practices often fall short. In response to this, a Delphi consensus group developed a risk assessment
questionnaire intended to guide the clinician and patient to an improved dialogue and under-
standing of risks associated with dental implants.25 In private practice settings in which this risk
assessment algorithm has been used, patient acceptance and clinician feedback have been positive.
Validation studies of the risk assessment algorithm are ongoing.
The use of comprehensive risk analysis before initiating implant treatment has beneﬁts for both
the patient and clinician. The patient will be better informed about treatment options and more
knowledgeable of aftercare needs and the consequences of noncompliance. The clinician will
beneﬁt from a realistic assessment of an adequately screened patient and have an informed patient
to work with should future complications occur. Finally, the trust that develops from such a
concerted effort to inform and educate enhances the dentist-patient relationship, which improves
treatment outcomes.26,27 n
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